Increased expression of both insulin receptor substrates 1 and 2 confers increased sensitivity to IGF-1 stimulated cell migration

Endocrine-Related Cancer

Volumn 16, Issue 2, 2009, Pages 635-647

  de Blaquière, Gail E ^a   May, Felicity E B ^a   Westley, Bruce R ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; SOMATOMEDIN C RECEPTOR; ANTIDIABETIC AGENT; INSULIN; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, HUMAN; IRS2 PROTEIN, HUMAN; SMALL INTERFERING RNA; SOMATOMEDIN C;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL MIGRATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HORMONAL REGULATION; HUMAN; HUMAN CELL; INSULIN SENSITIVITY; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; BREAST TUMOR; CELL MOTION; DRUG ANTAGONISM; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL MOVEMENT; ESTROGENS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN-LIKE GROWTH FACTOR I; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 67650498522     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-08-0216     Document Type: Article

References (54)

1. Altundag K & Ibrahim NK 2006 Aromatase inhibitors in breast cancer: an overview. Oncologist 11 553-562.
2. Bae SN, Arand G, Azzam H, Pavasant P, Torri J, Frandsen TL & Thompson EW 1993 Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in matrigel-based in vitro assays. Breast Cancer Research and Treatment 24 241-255.
3. Bartucci M, Morelli C, Mauro L, Ando S & Surmacz E 2001 Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Cancer Research 61 6747-6754.
4. Baserga R 2004 Targeting the IGF-1 receptor: from rags to riches. European Journal of Cancer 40 2013-2015.
5. Bernard L, Legay C, Adriaenssens E, Mougel A & Ricort JM 2006 Estradiol regulates the insulin-like growth factor-I (IGF-I) signalling pathway: a crucial role of phosphatidylinositol 3-kinase (PI 3-kinase) in estrogens requirement for growth of MCF-7 human breast carcinoma cells. Biochemical and Biophysical Research Communications 350 916-921.
6. Byron SA, Horwitz KB, Richer JK, Lange CA, Zhang X & Yee D 2006 Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells. British Journal of Cancer 95 1220-1228.
7. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH & Pollak M 1998 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279 563-566.
8. Chan CM, Martin LA, Johnston SR, Ali S & Dowsett M 2002 Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation. Journal of Steroid Biochemistry and Molecular Biology 81 333-341.
9. Chang Q, Li Y, White MF, Fletcher JA & Xiao S 2002 Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications. Cancer Research 62 6035-6038.
10. Choi YJ, Nam SJ, Son MJ, Kim DK, Kim JH, Yang JH, Kim MH, Song HS, Nam DH & Bang SI 2006 Erlotinib prevents pulmonary metastasis in curatively resected breast carcinoma using a mouse model. Oncology Reports 16 119-122.
11. Clayton SJ, May FEB & Westley BR 1997 IGFs control the regulation of oestrogen and progesterone receptor by oestrogens. Molecular and Cellular Endocrinology 128 57-68.
12. D'Ambrosio C, Keller SR, Morrione A, Lienhard GE, Baserga R & Surmacz E 1995 Transforming potential of the insulin receptor substrate 1. Cell Growth and Differentiation 6 557-562.
13. Davies M, Gupta S, Goldspink G & Winslet M 2006 The insulin-like growth factor system and colorectal cancer: clinical and experimental evidence. International Journal of Colorectal Disease 21 201-208.
14. Daws MR, Westley BR & May FEB 1996 Paradoxical effects of overexpression of the type I insulin-like growth factor (IGF) receptor on the responsiveness of human breast cancer cells to IGFs and estradiol. Endocrinology 137 1177-1186.
15. Doerr ME & Jones JI 1996 The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells. Journal of Biological Chemistry 271 2443-2447.
16. Donaghue C, Westley BR & May FEB 1999 Selective promoter usage of the human estrogen receptor gene and its regulation by estrogen. Molecular Endocrinology 13 1934-1950.
17. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M & Hankinson SE 2006 Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. Journal of the National Cancer Institute 98 1406-1415.
18. Gibson SL, Ma Z & Shaw LM 2007 Divergent roles for IRS-1 and IRS-2 in breast cancer metastasis. Cell Cycle 6 631-637.
19. Guvakova MA & Surmacz E 1997 Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Experimental Cell Research 231 149-162.
20. Hailey J, Maxwell E, Koukouras K, Bishop WR, Pachter JA & Wang Y 2002 Neutralizing anti-insulin-like growth factor receptor 1 antibodies inhibit receptor function and induce receptor degradation in tumor cells. Molecular Cancer Therapeutics 1 1349-1353.
21. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE & Pollak M 1998 Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351 1393-1396.
22. Hofmann F & Garcia-Echeverria C 2005 Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer. Drug Discovery Today 10 1041-1047.
23. Jackson JG, Zhang X, Yoneda T & Yee D 2001 Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines. Oncogene 20 7318-7325.
24. Kooijman R 2006 Regulation of apoptosis by insulin-like growth factor (IGF)-I. Cytokine and Growth Factor Reviews 17 305-323.
25. Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK & Yee D 1999 Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Molecular Endocrinology 13 787-796.
26. Lee BC, Lee TH, Avraham S & Avraham HK 2004 Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Molecular Cancer Research 2 327-338.
27. Li SL, Liang SJ, Guo N, Wu AM & Fujita-Yamaguchi Y 2000 Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth. Cancer Immunology and Immunotherapy 49 243-252.
28. Maloney EK, McLaughlin JL, Dagdigian NE, Garrett LM, Connors KM, Zhou XM, Blattler WA, Chittenden T & Singh R 2003 An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation. Cancer Research 63 5073-5083.
29. Mauro L, Salerno M, Panno ML, Bellizzi D, Sisci D, Miglietta A, Surmacz E & Ando S 2001 Estradiol increases IRS-1 gene expression and insulin signaling in breast cancer cells. Biochemical and Biophysical Research Communications 288 685-689.
30. Mazitschek R & Giannis A 2004 Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases. Current Opinion in Chemical Biology 8 432-441.
31. Mira E, Lacalle RA, Gonzalez MA, Gomez-Mouton C, Abad JL, Bernad A, Martinez AC & Manes S 2001 A role for chemokine receptor transactivation in growth factor signaling. EMBO Reports 2 151-156.
32. Molloy CA, May FEB & Westley BR 2000 Insulin receptor substrate-1 expression is regulated by estrogen in the MCF-7 human breast cancer cell line. Journal of Biological Chemistry 275 12565-12571.
33. Pandini G, Vigneri R, Costantino A, Frasca F, Ippolito A, Fujita-Yamaguchi Y, Siddle K, Goldfine ID & Belfiore A 1999 Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Clinical Cancer Research 5 1935-1944.
34. Pennisi PA, Barr V, Nunez NP, Stannard B & Le Roith D 2002 Reduced expression of insulin-like growth factor I receptors in MCF-7 breast cancer cells leads to a more metastatic phenotype. Cancer Research 62 6529-6537.
35. Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, Calabretta B & Baserga R 1999 Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Molecular and Cellular Biology 19 7203-7215.
36. Pollak M 2000 Insulin-like growth factor physiology and cancer risk. European Journal of Cancer 36 1224-1228.
37. Prest SJ, May FEB & Westley BR 2002 The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells. FASEB Journal 16 592-594.
38. Rocha RL, Hilsenbeck SG, Jackson JG, VanDenBerg CL, Weng C, Lee AV & Yee D 1997 Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. Clinical Cancer Research 3 103-109.
39. Sachdev D & Yee D 2001 The IGF system and breast cancer. Endocrine-Related Cancer 8 197-209.
40. Sachdev D & Yee D 2006 Inhibitors of insulin-like growth factor signaling: a therapeutic approach for breast cancer. Journal of Mammary Gland Biology and Neoplasia 11 27-39.
41. Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS & Yee D 2003 A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I. Cancer Research 63 627-635.
42. Schernhammer ES, Holly JM, Pollak MN & Hankinson SE 2005 Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention 14 699-704.
43. Stewart AJ, Johnson MD, May FEB & Westley BR 1990 Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. Journal of Biological Chemistry 265 21172-21178.
44. Stromberg T, Ekman S, Girnita L, Dimberg LY, Larsson O, Axelson M, Lennartsson J, Hellman U, Carlson K, Osterborg A et al. 2006 IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/ M-phase accumulation and apoptosis in multiple myeloma cells. Blood 107 669-678.
45. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ & White MF 1991 Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352 73-77.
46. Tanaka S & Wands JR 1996 A carboxy-terminal truncated insulin receptor substrate-1 dominant negative protein reverses the human hepatocellular carcinoma malignant phenotype. Journal of Clinical Investigation 98 2100-2108.
47. Tazzari PL, Tabellini G, Bortul R, Papa V, Evangelisti C, Grafone T, Martinelli G, McCubrey JA & Martelli AM 2007 The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion. Leukemia 21 886-896.
48. Vassen L, Wegrzyn W & Klein-Hitpass L 1999 Human insulin receptor substrate-2: gene organization and promoter characterization. Diabetes 48 1877-1880.
49. Wang Y, Hailey J, Williams D, Wang Y, Lipari P, Malkowski M, Wang X, Xie L, Li G, Saha D et al. 2005 Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody. Molecular Cancer Therapeutics 4 1214-1221.
50. Westley BR & May FEB 2006 Identification of steroid hormone regulated genes in breast cancer. Methods in Molecular Medicine 120 363-388.
51. Westley BR, Clayton SJ, Daws MR, Molloy CA & May FEB 1998 Interactions between the oestrogen and insulin-like growth factor signalling pathways in the control of breast epithelial cell proliferation. Biochemical Society Symposium 63 35-44.
52. White MF 2002 IRS proteins and the common path to diabetes. American Journal of Physiology 283 E413-E422.
53. Wickerham L 2002 Tamoxifen - an update on current data and where it can now be used. Breast Cancer Research and Treatment 75 S7-S12.
54. Yee D 2006 Targeting insulin-like growth factor pathways. British Journal of Cancer 94 465-468.